TNF Translationally Modulates the Expression of G Protein αi2 Subunits in Human Polymorphonuclear Leukocytes

Journal of Immunology

Volumn 158, Issue 2, 1997, Pages 913-918

  Scherzer, Janice A ^a   Lin, Ying ^a   McLeish, Kenneth R ^a   Klein, Jon B ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GNAI2 PROTEIN, HUMAN; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; ONCOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOSYNTHESIS; DRUG EFFECT; HUMAN; IMMUNOLOGY; METABOLISM; NEUTROPHIL; PROTEIN SYNTHESIS; TRANSPORT AT THE CELLULAR LEVEL; UPREGULATION;

BIOLOGICAL TRANSPORT; GTP-BINDING PROTEIN ALPHA SUBUNIT, GI2; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GTP-BINDING PROTEINS; HUMANS; NEUTROPHILS; PROTEIN BIOSYNTHESIS; PROTO-ONCOGENE PROTEINS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0031567911     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Snyderman, R., and R. J. Uhing. 1992. In Inflammation: Basic Principles and Clinical Correlates. J. I. Gallin, I. M. Goldstein, and R, Snyderman, eds. Raven Press, New York, pp. 421-439.
2. Walker, B. A., and P. A. Ward. 1992. Priming and signal transduction in neutrophils. Biol. Signals 1:237.
3. Atkinson, Y. H., A. F. Lopez, W. A. Marasco, C. M. Lucas, G. G. Wong, G. F. Burns, and M. A. Vadas. 1988. Recombinant human granulocyte-macrophage colony-stimulating factor (rHu GM-CSF) regulates fMet-Leu-Phe receptors on human neutrophils. Immunology 64:519.
4. Atkinson, Y. H., W. A. Marasco, A. F. Lopez, and M. A. Vadas. 1988. Recombinant tumor necrosis factor-α: regulation of N-formylmethionylleucylphenylalanine receptor affinity and function of human neutrophils. J. Clin. Invest. 81: 759.
5. Weisbart, R. H., D. W. Golde, and J. C. Gasson. 1986. Biosynthetic human GM-CSF modulates the number and affinity of neutrophil f-Met-Leu-Phc receptors. J. Immunol. 137:3584.
6. Klein, J. B., J. A. Scherzer, and K. R. McLeish. 1992. IFN-γ enhances expression of formyl peptide receptors and guanine nucleotide-binding proteins by HL-60 granulocytes. J. Immunol. 148:2483.
7. McLeish, K. R., J. B. Klein, T. Schepers, and G. Sonnenfeld. 1991. Modulation of transmembrane signalling in HL-60 granulocytes by tumor necrosis factor-α. Biochem. J. 279:455.
8. 4, and platelet-activating factor: dissociation from priming in human polymorphonuclear neutrophils. J. Immunol. 147:3842.
9. i-proteins mediate formyl peptide receptor signal transduction in human leukemia (HL-60) cells. J. Biol. Chem. 264:21470.
10. 4 and N-formylmethionyl-leucyl-phenylalanine in HL-60 cells occurs by different mechanisms. Biochem. J. 260:427.
11. 4 receptors. J. Biol. Chem. 267:159.
12. Jacobs, A. A., J. L. Huber, R. A. Ward, J. B. Klein, and K. R. McLeish. 1995. Chemoattractant receptor-specific differences in G protein activation rates regulate effector enzyme and functional responses. J. Leukocyte Biol. 57:679.
13. Polakis, P. G., R. J. Uhing, and R. Snyderman. 1988. The formyl peptide chemoattractant receptor copurifies with a GTP-binding protein containing a distinct 40-kDa pertussis toxin substrate. J. Biol. Chem. 263:4969.
14. i complex. Proc. Natl. Acad. Sci. USA 88:971.
15. McColl, S. R., D. Beauseigle, C. Gilbert, and P. H. Naccache. 1990. Priming of the human neutrophil respiratory burst by granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-a involves regulation at a post-cell surface receptor level: enhancement of the effect of agents which directly activate G proteins. J. Immunol. 145:3047.
16. i2 associated with the plasma membrane in human neutrophils stimulated by granulocyte-macrophage colony-stimulating factor. Biochem. J. 292:183.
17. Yasui, K., E. L. Becker, and R. I. Sha'afi. 1992. Lipopolysaccharide and serum cause the translocation of G-protein to the membrane and prime neutrophils via CD14. Biochem. Biophys. Res. Commun. 183:1280.
18. Klein, J. B., J. A. Scherzer, G. Harding, A. A. Jacobs, and K. R. McLeish. 1995. TNF-α stimulates increased plasma membrane guanine nucleotide binding protein activity in polymorphonuclear leukocytes. J. Leukocyte Biol. 57:500.
19. Goldsmith, P., P. Gierschik, G. Milligan, C. G. Unson, R. Vinitsky, H. L. Malech, and A. M. Spiegel. 1987. Antibodies directed against synthetic peptides distinguish between GTP-binding proteins in neutrophil and brain. J. Biol. Chem. 262: 14683.
20. Gierschik, P., J. Falloon, G. Milligan, M. Pines, J. I. Gallin, and A. Spiegel. 1986. Immunochemical evidence for a novel pertussis toxin substrate in human neutrophils. J. Biol. Chem. 261:8058.
21. Marucha, P. T., R. A. Zeff, and D. L. Kreutzer. 1991. Cytokine-induced IL-1β gene expression in the human polymorphonuclear leukocyte: transcriptional and post-transcriptional regulation by tumor necrosis factor and IL-1. J. Immunol. 147:2603.
22. Sambrook, J., E. F. Frisch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor Laboratory, Cold Spring Harbor.
23. Botto, M., D. Lissandrini, C. Sorio, and M. J. Walport. 1992. Biosynthesis and secretion of complement component (C3) by activated human polymorphonuclear leukocytes. J. Immunol. 149:1348.
24. Fujishima, S., A. R. Hoffman, T. Vu, K. J. Kim, H. Zheng, D. Daniel, Y. Kim, E. F. Wallace, J. W. Larrick, and T. A. Raffin. 1993. Regulation of neutrophil interleukin 8 gene expression and protein secretion by LPS, TNF-α, and IL-1β. J. Cell. Physiol. 154:478.
25. Waterman, W. H., and R. I. Sha'afi. 1995. Effects of granulocyte-macrophage colony-stimulating factor and rumour necrosis factor-α on tyrosine phosphorylation and activation of mitogen-activated protein kinases in human neutrophils. Biochem. J. 307:39.
26. Jack, R. M., and D. T. Fearon. 1988. Selective synthesis of mRNA and proteins by human peripheral blood neutrophils. J. Immunol. 140:4286.
27. McColl, S. R., R. Paquin, and A. D. Beaulieu. 1990. Selective synthesis and secretion of a 23-kD protein by neutrophils following stimulation with granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha. Biochem. Biophys. Res. Commun. 172:1209.
28. McColl, S. R., R. Paquin, C. Menard, and A. D. Beaulieu. 1992. Human neutrophils produce high levels of the interleukin 1 receptor antagonist in response to granulocyte/macrophage colony-stimulating factor and tumor necrosis factor-α. J. Exp. Med. 176:593.
29. Malyak, M., M. F. Smith, A. A. Abel, and W. P. Arend. 1994. Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1β. J. Clin. Immunol. 14:20.
30. Scheurich, P., M. Kranke, C. Schluter, U. Ucer, and K. Pfizenmaier. 1986. Noncytocidal mechanisms of action of tumor necrosis factor-α on human tumor cells: enhancement of HLA gene expression synergistic with interferon-γ. Immunobiology 172:201.
31. Collins, T., L. A. Lapierre, W. Fiers, J. L. Strominger, and J. S. Pober. 1986. Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro. Proc. Natl. Acad. Sci. USA 83:446.
32. Pfizenmaier, K., P. Scheurich, C. Schluter, and M. Kronke. 1987. Tumor necrosis factor enhances HLA-A,B,C and HLA-DR gene expression in human tumor cells. J. Immunol. 138:975.
33. Freimuth, W. W., J. M. Depper, and G. J. Nabel. 1989. Regulation of the IL-2 receptor a gene: interaction of a κB binding protein with cell-specific transcription factors. J. Immunol. 143:3064.
34. Campbell, I. K., J. Wojta, U. Novak, and J. A. Hamilton. 1994. Cytokine modulation of plasminogen activator inhibitor-1 (PAI-1) production by human articular cartilage and chondrocytes. Biochim. Biophys. Acta 1226:277.
35. Kohno, K., R. Hamanake, T. Abe, Y. Nomura, A. Morimoto, H. Izumi, K. Shimizu, M. Ono, and M. Kuwano. 1993. Morphological change and destabilization of β-actin mRNA by tumor necrosis factor in human microvascular endothelial cells. Exp. Cell Res. 208:498.
36. Yoshizumi, M., M. A. Perrella, J. C. Burnett, Jr., and M. E. Lee. 1993. Tumor necrosis factor down-regulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ. Res. 73:205.
37. Wisdom, R., and W. Lee. 1990. Translation of c-myc mRNA is required for its post-transcriptional regulation during myogenesis. J. Biol. Chem. 265:19015.
38. Wisdom, R., and W. Lee. 1991. The protein-coding region of c-myc mRNA contains a sequence that specifies rapid mRNA turnover and induction by protein synthesis inhibitors. Genes Dev. 5:232.
39. Herrick, D. J., and J. Ross. 1994. The half-life of c-myc mRNA in growing and serum-stimulated cells: influence of the coding and 3′ untranslated regions and role of ribosome translocation. Mol Cell Biol. 14:2119.
40. Yen, T. J., D. A. Gay, J. S. Pachter, and D. W. Cleveland. 1988. Autoregulated changes in stability of polyribosome-bound β-tubulin mRNAs are specified by the first 13 translated nucleotides. Mul. Cell Biol. 8:1224.
41. Yen, T. J., P. S. Machlin, and D. W. Cleveland. 1988. Autoregulated instability of β-tubulin mRNAs by recognition of the nascent amino terminus of β-tubulin. Nature 334:580.
42. Gay, D. A., S. S. Sisodia, and D. W. Cleveland. 1989. Autoregulated control of β-tubulin mRNA stability is linked to translational elongation. Proc. Natl. Acad. Sci. USA 86:5763.
43. Theodorakis, N. G., and D. W. Cleveland. 1992. Physical evidence for cotranslational regulation of β-tubulin mRNA degradation. Mol Cell. Biol. 12:791.
44. Bachurski, C. J., N. G. Theodorakis, R. M. R. Coulson, and D. W. Cleveland. 1994. An amino-terminal tetrapeptide specifies cotranslational degradation of β-tubulin but not a-tubulin mRNAs. Mol. Cell. Biol. 14:4076.